Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001213900-22-000805 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-05 | 2022-01-03 | ORMP | Silberman David | CFO | A - Grant | — | +19.0K | 69.0K | +38% | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | Silberman David | CFO | A - Grant | $0.00 | +32.0K | 32.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | A | A | 19,000 | — | 69,000 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. |
| 2 | Derivative | Stock Option (right to buy) | 2022-01-03 | A | A | 32,000 | $0.00 | 32,000 | D | $13.89 · — to 2032-01-03 | 32,000 Common Stock | (F2) The Stock Option will vest in 4 installments as follows: 8,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. |